Yiren Xiao

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models”.

Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination–deficient cancer models

Journal of Clinical Investigation(2021)10.1172/jci146256

N/A

0.997DataRank · unranked

39 citations

Yu Xu, Caiyun G. Li, Eui Jung Moon, Kaushik N. Thakkar, Anh N. Diep +10 more

Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.19.911941

N/A

0.165DataRank · unranked

2 citations

Kaushik N. Thakkar, Jin Qian, Mihalis S. Kariolis, Huang Wei, Saravanan Nandagopal +13 more

Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-0482

N/A

0DataRank · unranked

59 citations

Kaushik N. Thakkar, Jin Qian, Mihalis S. Kariolis, Wei Huang, Saravanan Nandagopal +13 more